Journal of Cancer Therapy

Vol.9 No.5(2018), Paper ID 84767, 25 pages

DOI:10.4236/jct.2018.95038

 

Tamoxifen Treatment in Correlation with Increased ET-1 Levels Is Associated with the Development of Breast Cancer Metastases

 

Melanie von Brandenstein, Julia Straube, Christina-Maria Geisbüsch, Luka Ozretić, Yasemin Ural, Verena Kirn, Wolfram Malter, Jochen W. U. Fries

 

Department of Urology, University Hospital of Koeln, Koeln, Germany
Department of Molecular and Experimental Surgery, University Hospital Erlangen, Erlangen, Germany
Department of Pediatric and Adolescent Psychiatry, Psychsomatic and Psychotherapy University Clinic RTWH Aachen, Germany
Department of Cellular Pathology, Royal Free Hospital, London, UK
Department of Urology, University Hospital of Koeln, Koeln, Germany
Department of Gynecology and Obstetrics, University Hospital of Koeln, Koeln, Germany
Department of Gynecology and Obstetrics, University Hospital of Koeln, Koeln, Germany
Department of Pathology, University Hospital of Koeln, Koeln, Germany

 

Copyright © 2018 Melanie von Brandenstein, Julia Straube, Christina-Maria Geisbüsch, Luka Ozretić, Yasemin Ural, Verena Kirn, Wolfram Malter, Jochen W. U. Fries et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


von Brandenstein, M. , Straube, J. , Geisbüsch, C. , Ozretić, L. , Ural, Y. , Kirn, V. , Malter, W. and W. U. Fries, J. (2018) Tamoxifen Treatment in Correlation with Increased ET-1 Levels Is Associated with the Development of Breast Cancer Metastases. Journal of Cancer Therapy, 9, 438-463. doi: 10.4236/jct.2018.95038.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.